Methocarbamol in Ventral and Inguinal HR

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

164

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Ventral HerniaInguinal Hernia

Interventions

DRUG

Methocarbamol

Methocarbamol after surgery

DRUG

Standard Opioid

Standard opioid after surgery or at discharge

DRUG

Standard opioid plus methocarbamol

Standard opioid plus methocarbamol after surgery or at discharge

Trial Locations (1)

Prisma Health, Greenville

All Listed Sponsors

lead

Prisma Health-Upstate

OTHER

NCT05388929 - Methocarbamol in Ventral and Inguinal HR | Biotech Hunter | Biotech Hunter